Founders Financial Alliance’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$808K Buy
33,547
+1,194
+4% +$31.2K 0.11% 181
2026
Q1
$908K Buy
32,353
+566
+2% +$15.1K 0.16% 132
2025
Q4
$791K Buy
31,787
+249
+0.8% +$6.28K 0.15% 135
2025
Q3
$804K Buy
31,538
+1,693
+6% +$41.8K 0.15% 137
2025
Q2
$723K Buy
29,845
+1,665
+6% +$38.8K 0.16% 130
2025
Q1
$714K Buy
28,180
+763
+3% +$20K 0.17% 123
2024
Q4
$727K Sell
27,417
-803
-3% -$21.8K 0.2% 109
2024
Q3
$817K Sell
28,220
-199
-0.7% -$5.8K 0.23% 99
2024
Q2
$795K Buy
28,419
+995
+4% +$27.4K 0.24% 96
2024
Q1
$761K Sell
27,424
-3,062
-10% -$85K 0.23% 98
2023
Q4
$878K Buy
30,486
+666
+2% +$20.1K 0.34% 69
2023
Q3
$989K Sell
29,820
-2,473
-8% -$87.5K 0.43% 49
2023
Q2
$1.18M Buy
32,293
+2,822
+10% +$110K 0.47% 45
2023
Q1
$1.2M Sell
29,471
-1,295
-4% -$55.9K 0.6% 37
2022
Q4
$1.58M Buy
30,766
+170
+0.6% +$8.15K 0.72% 33
2022
Q3
$1.34M Buy
30,596
+4,801
+19% +$233K 0.68% 34
2022
Q2
$1.35M Sell
25,795
-2,432
-9% -$124K 0.69% 35
2022
Q1
$1.46M Buy
28,227
+1,025
+4% +$53.2K 0.65% 35
2021
Q4
$1.61M Buy
27,202
+543
+2% +$26.9K 0.65% 33
2021
Q3
$1.15M Buy
26,659
+3,217
+14% +$143K 0.54% 46
2021
Q2
$920K Buy
23,442
+15
+0.1% +$583 0.42% 59
2021
Q1
$905K Buy
23,427
+529
+2% +$18.8K 0.45% 53
2020
Q4
$847K Buy
22,898
+106
+0.5% +$3.89K 0.48% 50
2020
Q3
$798K Buy
+22,792
New +$799K 0.48% 45

Other funds holding PFE

Founders Financial Alliance's PFE Position: Q2 2026 in Review

Founders Financial Alliance increased its Pfizer (PFE) stake by 3.7% in Q2 2026, buying an estimated $31.2K and bringing the position to 33,547 shares worth $808K. The position accounts for 0.11% of the portfolio, ranked #181.

Founders Financial Alliance first reported a position in PFE in Q3 2020 and has held it in 24 quarters since. The position peaked at $1.61M in Q4 2021. 2,823 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Founders Financial Alliance held 33,547 shares of Pfizer worth $808K as of Q2 2026.
  • Founders Financial Alliance bought 1,194 Pfizer shares in Q2 2026, an estimated $31.2K.
  • Pfizer made up 0.11% of Founders Financial Alliance's portfolio in Q2 2026, its #181 holding.
  • Founders Financial Alliance first reported a position in Pfizer in Q3 2020 and has held it in 24 quarters since.
  • Founders Financial Alliance's Pfizer position peaked at $1.61M in Q4 2021.
  • 2,823 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Founders Financial Alliance's 13F filing for Q2 2026, filed 4 Aug 2026.